571 related articles for article (PubMed ID: 19015922)
1. Effectiveness of peripheral thyrotropin receptor mRNA in follow-up of differentiated thyroid cancer.
Milas M; Barbosa GF; Mitchell J; Berber E; Siperstein A; Gupta M
Ann Surg Oncol; 2009 Feb; 16(2):473-80. PubMed ID: 19015922
[TBL] [Abstract][Full Text] [Related]
2. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
[TBL] [Abstract][Full Text] [Related]
3. Circulating thyroglobulin mRNA does not predict early and midterm recurrences in patients undergoing thyroidectomy for cancer.
Lombardi CP; Bossola M; Princi P; Boscherini M; La Torre G; Raffaelli M; Traini E; Salvatori M; Pontecorvi A; Bellantone R
Am J Surg; 2008 Sep; 196(3):326-32. PubMed ID: 18614150
[TBL] [Abstract][Full Text] [Related]
4. The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer.
Aliyev A; Soundararajan S; Bucak E; Gupta M; Hatipoglu B; Nasr C; Siperstein A; Berber E
Surgery; 2015 Oct; 158(4):1089-93; discussion 1093-4. PubMed ID: 26212344
[TBL] [Abstract][Full Text] [Related]
5. Quantitative reverse transcription-polymerase chain reaction of circulating thyroglobulin messenger ribonucleic acid for monitoring patients with thyroid carcinoma.
Ringel MD; Balducci-Silano PL; Anderson JS; Spencer CA; Silverman J; Sparling YH; Francis GL; Burman KD; Wartofsky L; Ladenson PW; Levine MA; Tuttle RM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4037-42. PubMed ID: 10566646
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating thyroid cancer cells in patients with thyroid microcarcinomas.
Novosel T; Ritter HE; Gupta M; Harvey A; Mitchell J; Berber E; Siperstein A; Milas M
Surgery; 2009 Dec; 146(6):1081-9. PubMed ID: 19958935
[TBL] [Abstract][Full Text] [Related]
7. Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.
Giovanella L; Ceriani L; Ghelfo A; Maffioli M; Keller F
Clin Endocrinol (Oxf); 2007 Oct; 67(4):547-51. PubMed ID: 17561976
[TBL] [Abstract][Full Text] [Related]
8. Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin.
Kaufmann S; Schmutzler C; Schomburg L; Körber C; Luster M; Rendl J; Reiners C; Köhrle J
Endocr Regul; 2004 Jun; 38(2):41-9. PubMed ID: 15497927
[TBL] [Abstract][Full Text] [Related]
9. Detection of thyrotropin-receptor messenger ribonucleic acid (mRNA) and thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease: sensitive and specific markers for thyroid cancer.
Chinnappa P; Taguba L; Arciaga R; Faiman C; Siperstein A; Mehta AE; Reddy SK; Nasr C; Gupta MK
J Clin Endocrinol Metab; 2004 Aug; 89(8):3705-9. PubMed ID: 15292293
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of quantitative measurement of thyroglobulin mRNA in the follow-up of differentiated thyroid cancer.
Denizot A; Delfino C; Dutour-Meyer A; Fina F; Ouafik L
Thyroid; 2003 Sep; 13(9):867-72. PubMed ID: 14588101
[TBL] [Abstract][Full Text] [Related]
11. Thyroglobulin monitoring after treatment of well-differentiated thyroid cancer.
Hamy A; Mirallié E; Bennouna J; Resche I; Drefty C; Johnstone M; Visset J
Eur J Surg Oncol; 2004 Aug; 30(6):681-5. PubMed ID: 15256244
[TBL] [Abstract][Full Text] [Related]
12. Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance.
Barbosa GF; Milas M
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1415-24. PubMed ID: 18759693
[TBL] [Abstract][Full Text] [Related]
13. Thyroid-stimulating hormone receptor messenger ribonucleic acid measurement in blood as a marker for circulating thyroid cancer cells and its role in the preoperative diagnosis of thyroid cancer.
Chia SY; Milas M; Reddy SK; Siperstein A; Skugor M; Brainard J; Gupta MK
J Clin Endocrinol Metab; 2007 Feb; 92(2):468-75. PubMed ID: 17118994
[TBL] [Abstract][Full Text] [Related]
14. [Recovery test or immunoradiometric measurement of anti-thyroglobulin autoantibodies for interpretation of thyroglobulin determination in the follow-up of different thyroid carcinoma].
Zöphel K; Wunderlich G; Liepach U; Koch R; Bredow J; Franke WG
Nuklearmedizin; 2001 Oct; 40(5):155-63. PubMed ID: 11727628
[TBL] [Abstract][Full Text] [Related]
15. Real-time quantitative PCR measurement of thyroglobulin mRNA in peripheral blood of thyroid cancer patients and healthy subjects.
Li D; Butt A; Clarke S; Swaminathana R
Ann N Y Acad Sci; 2004 Jun; 1022():147-51. PubMed ID: 15251954
[TBL] [Abstract][Full Text] [Related]
16. Quantitative measurement of thyroglobulin mRNA in peripheral blood of patients after total thyroidectomy.
Takano T; Miyauchi A; Yoshida H; Hasegawa Y; Kuma K; Amino N
Br J Cancer; 2001 Jul; 85(1):102-6. PubMed ID: 11437410
[TBL] [Abstract][Full Text] [Related]
17. Circulating thyroid cancer markers.
Gupta M; Chia SY
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
[TBL] [Abstract][Full Text] [Related]
18. Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples.
Milas M; Shin J; Gupta M; Novosel T; Nasr C; Brainard J; Mitchell J; Berber E; Siperstein A
Ann Surg; 2010 Oct; 252(4):643-51. PubMed ID: 20881771
[TBL] [Abstract][Full Text] [Related]
19. Value of serum thyroglobulin measurement in patients operating on for well differentiated thyroid carcinoma.
Rüter A; Smeds S; Lennquist S
Eur J Surg; 1998 Sep; 164(9):665-71. PubMed ID: 9728785
[TBL] [Abstract][Full Text] [Related]
20. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid.
Suh I; Vriens MR; Guerrero MA; Griffin A; Shen WT; Duh QY; Clark OH; Kebebew E
Am J Surg; 2010 Jul; 200(1):41-6. PubMed ID: 20637335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
